information
Whoever comes in this website may find a hint
Phage therapy is influenced by:
Phage therapy is influenced by:
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".
"In silico"
From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson
Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.
Showing posts with label Antibiotic resistance. Show all posts
Showing posts with label Antibiotic resistance. Show all posts
Saturday, 18 July 2015
Monday, 6 April 2015
The Guardian: outbreak of drug-resistant infection could kill 80,000 in UK, report warns
Link
“Much of modern medicine (for example, organ transplantation, bowel surgery and some cancer treatments) may become unsafe due to the risk of infection."
“In addition, influenza pandemics would become more serious without effective treatments.”
“If we don’t take action, in 20 years’ time we could be back in the 19th century where infections kill us as a result of routine operations.”
“Much of modern medicine (for example, organ transplantation, bowel surgery and some cancer treatments) may become unsafe due to the risk of infection."
“In addition, influenza pandemics would become more serious without effective treatments.”
“If we don’t take action, in 20 years’ time we could be back in the 19th century where infections kill us as a result of routine operations.”
Wednesday, 2 July 2014
Tuesday, 17 June 2014
ESKAPE bacteria
From Medscape Infectious Diseases:
Emerging Antibiotics: Will We Have What We Need?
" * More US patients die of MRSA infections than HIV/AIDS and tuberculosis combined.
* Only 2 new antibiotics -- doripenem and telavancin -- have been approved in the past 3 years.
* We have no drugs to treat infections with some strains of multi-drug-resistant gram-negative bacilli, like Pseudomonas aeruginosa and Acinetobacter baumannii.We may finally have arrived at the era of the untreatable bacterial infection."The ESKAPE ( they effectively escape the effects of antibiotics)
Emerging Antibiotics: Will We Have What We Need?
" * More US patients die of MRSA infections than HIV/AIDS and tuberculosis combined.
* Only 2 new antibiotics -- doripenem and telavancin -- have been approved in the past 3 years.
* We have no drugs to treat infections with some strains of multi-drug-resistant gram-negative bacilli, like Pseudomonas aeruginosa and Acinetobacter baumannii.We may finally have arrived at the era of the untreatable bacterial infection."The ESKAPE ( they effectively escape the effects of antibiotics)
E | Enterococcus faecium | Third most common cause of HCA BSI. Increasing resistance to vancomycin. |
S | Staphylococcus aureus (MRSA) | Emerging resistance to current drugs and significant drug toxicities. Lack of oral agents for step-down therapy |
K | Klebsiella Escherichia coli K pneumoniae |
ESBL-producing organisms increasing in frequency and severity; associated with increasing mortality. K pneumoniae carbapenemases causing severe infections in LTCF. Few active agents; nothing in development |
A | Acinetobacter baumannii | Increasing worldwide, recent surge reported in hospitals. Very high mortality. Carbapenem-resistant. |
P | Pseudomonas aeruginosa | Increasing P. aeruginosa infections in US and worldwide. Resistant to carbapenems, quinolones, aminoglycosides |
E | Enterobacter species | MDR HCA infections increasing; resistance via ESBLs, carbapenemases, and cephalosporinases |
Sunday, 15 June 2014
Antibiotic resistance: a worldwide problem
" ANTIMICROBIAL RESISTANCE,Global Report on surveillance"
A post-antibiotic era—in which common infections and minor injuries can kill—far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century.
Image
Link
Escherichia coli: Resistance to third-generation cephalosporins
Escherichia coli: Resistance to fluoroquinolones
Klebsiella pneumoniae: Resistance to third-generation cephalosporins
Klebsiella pneumoniae: Resistance to carbapenems
Staphylococcus aureus: Resistance to methicillin (MRSA)
Streptococcus pneumoniae: Resistance, or non-susceptibility, to penicillin
Nontyphoidal Salmonella (NTS): Resistance to fluoroquinolones
Shigella species: Resistance to fluoroquinolones
Neisseria gonorrhoeae: Decreased susceptibility to third-generation cephalosporins.
Subscribe to:
Posts (Atom)